In the present study, we aimed to investigate whether NR3C1 methylation status was correlated with known cardiovascular markers at the early phase of ACS, and whether it was associated with the long-term prognosis of ACS considering the negative impact of depression on these outcomes. This evidence concerns the gene NR3C1 and depressive disorder.